Volume 28, Number 10—October 2022
Research Letter
Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
Figure

Figure. Distribution of sVNT by month after second and third doses of CoronaVac vaccine (Sinovac, https://www.sinovac.com) among persons living with HIV, Hong Kong. Horizontal lines inside boxes indicate medians, box tops and bottoms indicate 25th and 75th percentiles, and error bars indicate high and low values excluding outliers. Blue asterisk and red dots indicate outliers. Gray line indicates cutoff of 30% for positive neutralizing response. sVNT, surrogate virus neutralization test.
Page created: August 25, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.